What are Uterine Fibroids

Uterine fibroids, also known as leiomyomas, are non-cancerous, monoclonal tumors that originate from the smooth muscle cells of the uterine wall.

Understanding Uterine Fibroids

While uterine fibroids are technically benign growths, they can significantly impact a patient’s quality of life by affecting the reproductive and urinary systems. Because they develop within or on the uterus, they can press against the bladder, causing frequent urination, or push against the bowel, leading to constipation or pelvic pressure. In many cases, these growths lead to heavy menstrual bleeding, which may result in iron-deficiency anemia.

Classification and Prevalence

Uterine fibroids are categorized by their location within the uterus: intramural (within the muscular wall), submucosal (protruding into the uterine cavity), and subserosal (growing on the outer surface of the uterus). While often discussed as a common condition, they are considered a significant health burden globally; research suggests that by age 50, up to 70–80% of women may develop uterine fibroids, though many remain asymptomatic and undiagnosed.

Who is Affected and Why?

These growths typically appear during the reproductive years, most commonly between the ages of 30 and 50. They are estrogen- and progesterone-dependent, meaning they require these hormones to grow, which explains why they often shrink after menopause. While the exact cause remains under investigation, the pathophysiology involves a combination of genetic mutations, hormonal influence, and changes in the extracellular matrix. Unlike uterine sarcomas, which are rare and malignant, uterine fibroids have a very low risk of becoming cancerous.

Differentiation

What sets uterine fibroids apart from conditions like adenomyosis or endometriosis is their distinct, encapsulated nature. While other conditions involve the spread or infiltration of endometrial tissue, fibroids act as discrete "knots" of muscle, allowing for specific surgical interventions like myomectomy to remove the growth while preserving the uterus.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Please consult with a healthcare professional or a reproductive endocrinologist for a personalized diagnosis and treatment plan.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Uterine Fibroids


• Office on Women’s Health (OWH): Uterine Fibroids Overview


• Orphanet: Rare Diseases Database


• American College of Obstetricians and Gynecologists (ACOG)